▶ 調査レポート

神経変性疾患の世界市場 2019年

• 英文タイトル:Global Neurodegenerative Disease Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。神経変性疾患の世界市場 2019年 / Global Neurodegenerative Disease Sales Market Report 2019 / QYR9G06688資料のイメージです。• レポートコード:QYR9G06688
• 出版社/出版日:QYResearch / 2019年8月12日
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥440,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥880,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、神経変性疾患の世界市場について調査・分析し、神経変性疾患のメーカー別販売量、市場シェア分析、種類別販売分析(NMDA、SSRI、ドーパミン阻害剤)、用途別販売分析(Parkinson’s Disease、Huntington Disease、Amyotrophic Lateral Sclerosis、Alzheimer’s Disease)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・神経変性疾患市場概要
・神経変性疾患のメーカー別販売量・メーカー別シェア
・神経変性疾患の種類別販売量(NMDA、SSRI、ドーパミン阻害剤)
・神経変性疾患の用途別販売量(Parkinson’s Disease、Huntington Disease、Amyotrophic Lateral Sclerosis、Alzheimer’s Disease)
・神経変性疾患の地域別販売量・市場シェア
・神経変性疾患のアメリカ市場規模(2014年-2019年)
・神経変性疾患のヨーロッパ市場規模(2014年-2019年)
・神経変性疾患の中国市場規模(2014年-2019年)
・神経変性疾患の日本市場規模(2014年-2019年)
・神経変性疾患の東南アジア市場規模(2014年-2019年)
・神経変性疾患のインド市場規模(2014年-2019年)
・神経変性疾患メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・神経変性疾患のコスト分析
・神経変性疾患販売チャネル、流通業者、顧客
・神経変性疾患の世界市場動向・機会・成長要因・課題
・神経変性疾患の種類別世界市場予測(NMDA、SSRI、ドーパミン阻害剤)
・神経変性疾患の用途別世界市場予測(Parkinson’s Disease、Huntington Disease、Amyotrophic Lateral Sclerosis、Alzheimer’s Disease)
・神経変性疾患のアメリカ市場予測(2019年-2025年)
・神経変性疾患のヨーロッパ市場予測(2019年-2025年)
・神経変性疾患の中国市場予測(2019年-2025年)
・神経変性疾患の日本市場予測(2019年-2025年)
・神経変性疾患の東南アジア市場予測(2019年-2025年)
・神経変性疾患のインド市場予測(2019年-2025年)
...

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.
The global Neurodegenerative Disease market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Neurodegenerative Disease market status and forecast, categorizes the global Neurodegenerative Disease market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
NMDA
SSRIs
Dopamine Inhibitors

Segment by Application
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease

レポート目次

Table of Contents

Global Neurodegenerative Disease Sales Market Report 2019
1 Neurodegenerative Disease Market Overview
1.1 Neurodegenerative DiseaseProduct Overview
1.2 Neurodegenerative Disease Segment by Type
1.2.1 Global Neurodegenerative Disease Sales Comparison by Types (2014-2025)
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Neurodegenerative Disease Segment by Application
1.3.1 Global Neurodegenerative Disease Sales Comparison by Application (2014-2025)
1.3.1 Parkinson’s Disease
1.3.2 Huntington Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Alzheimer’s Disease
1.4 Neurodegenerative Disease Market by Region
1.4.1 Global Neurodegenerative Disease Revenue Comparison by Region (2014-2025)
1.4.2 United States Neurodegenerative Disease Status and Prospect (2014-2025)
1.4.3 Europe Neurodegenerative Disease Status and Prospect (2014-2025)
1.4.4 China Neurodegenerative Disease Status and Prospect (2014-2025)
1.4.5 Japan Neurodegenerative Disease Status and Prospect (2014-2025)
1.4.6 Southeast Asia Neurodegenerative Disease Status and Prospect (2014-2025)
1.4.7 India Neurodegenerative Disease Status and Prospect (2014-2025)
1.5 Global Neurodegenerative Disease Sales and Revenue (2014-2025)
1.5.1 Global Neurodegenerative Disease Sales and Growth Rate (2014-2025)
1.5.2 Global Neurodegenerative Disease Revenue and Growth Rate (2014-2025)

2 Neurodegenerative Disease by Company, Region, Type and Application
2.1 Global Neurodegenerative Disease Market Competition by Companies
2.1.1 Global Neurodegenerative Disease Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Neurodegenerative Disease Revenue Market Share by Company (2014-2019)
2.2 Global Neurodegenerative Disease Sales and Revenue by Region
2.2.1 Global Neurodegenerative Disease Sales Market Share by Region (2014-2019)
2.2.2 Global Neurodegenerative Disease Revenue Market Share by Region (2014-2019)
2.3 Global Neurodegenerative Disease Sales and Revenue by Type
2.3.1 Global Neurodegenerative Disease Sales Market Share by Type (2014-2019)
2.3.2 Global Neurodegenerative Disease Revenue Market Share by Type (2014-2019)
2.4 Global Neurodegenerative Disease Sales by Application

3 United States Neurodegenerative Disease Sales, Revenue and Price
3.1 United States Neurodegenerative Disease Sales and Revenue (2014-2019)
3.1.1 United States Neurodegenerative Disease Sales Growth Rate (2014-2019)
3.1.2 United States Neurodegenerative Disease Revenue Growth Rate (2014-2019)
3.1.3 United States Neurodegenerative Disease Price Trend (2014-2019)
3.2 United States Neurodegenerative Disease Sales Market Share by Company
3.3 United States Neurodegenerative Disease Sales Market Share by Type
3.4 United States Neurodegenerative Disease Sales Market Share by Application

4 Europe Neurodegenerative Disease Sales, Revenue and Price
4.1 Europe Neurodegenerative Disease Sales and Value (2014-2019)
4.1.1 Europe Neurodegenerative Disease Sales Growth Rate (2014-2019)
4.1.2 Europe Neurodegenerative Disease Revenue Growth Rate (2014-2019)
4.1.3 Europe Neurodegenerative Disease Price Trend (2014-2019)
4.2 Europe Neurodegenerative Disease Sales Market Share by Company
4.3 Europe Neurodegenerative Disease Sales Market Share by Type
4.4 Europe Neurodegenerative Disease Sales Market Share by Application

5 China Neurodegenerative Disease Sales, Revenue and Price
5.1 China Neurodegenerative Disease Sales and Revenue (2014-2019)
5.1.1 China Neurodegenerative Disease Sales Growth Rate (2014-2019)
5.1.2 China Neurodegenerative Disease Revenue Growth Rate (2014-2019)
5.1.3 China Neurodegenerative Disease Price Trend (2014-2019)
5.2 China Neurodegenerative Disease Sales Market Share by Company
5.3 China Neurodegenerative Disease Sales Market Share by Type
5.4 China Neurodegenerative Disease Sales Market Share by Application

6 Japan Neurodegenerative Disease Sales, Revenue and Price
6.1 Japan Neurodegenerative Disease Sales and Value (2014-2019)
6.1.1 Japan Neurodegenerative Disease Sales Growth Rate (2014-2019)
6.1.2 Japan Neurodegenerative Disease Revenue Growth Rate (2014-2019)
6.1.3 Japan Neurodegenerative Disease Price Trend (2014-2019)
6.2 Japan Neurodegenerative Disease Sales Market Share by Company
6.3 Japan Neurodegenerative Disease Sales Market Share by Type
6.4 Japan Neurodegenerative Disease Sales Market Share by Application

7 Southeast Asia Neurodegenerative Disease Sales, Revenue and Price
7.1 Southeast Asia Neurodegenerative Disease Sales and Value (2014-2019)
7.1.1 Southeast Asia Neurodegenerative Disease Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Neurodegenerative Disease Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Neurodegenerative Disease Price Trend (2014-2019)
7.2 Southeast Asia Neurodegenerative Disease Sales Market Share by Company
7.3 Southeast Asia Neurodegenerative Disease Sales Market Share by Type
7.4 Southeast Asia Neurodegenerative Disease Sales Market Share by Application

8 India Neurodegenerative Disease Sales, Revenue and Price
8.1 India Neurodegenerative Disease Sales and Value (2014-2019)
8.1.1 India Neurodegenerative Disease Sales Growth Rate (2014-2019)
8.1.2 India Neurodegenerative Disease Revenue Growth Rate (2014-2019)
8.1.3 India Neurodegenerative Disease Price Trend (2014-2019)
8.2 India Neurodegenerative Disease Sales Market Share by Company
8.3 India Neurodegenerative Disease Sales Market Share by Type
8.4 India Neurodegenerative Disease Sales Market Share by Application

9 Company Profiles and Key Figures in Neurodegenerative Disease Business
9.1 Novartis
9.1.1 Novartis Neurodegenerative Disease Production Sites and Area Served
9.1.2 Neurodegenerative Disease Specification and Application
9.1.3 Novartis Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Pfizer
9.2.1 Pfizer Neurodegenerative Disease Production Sites and Area Served
9.2.2 Neurodegenerative Disease Specification and Application
9.2.3 Pfizer Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Merck Serono
9.3.1 Merck Serono Neurodegenerative Disease Production Sites and Area Served
9.3.2 Neurodegenerative Disease Specification and Application
9.3.3 Merck Serono Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Biogen Idec
9.4.1 Biogen Idec Neurodegenerative Disease Production Sites and Area Served
9.4.2 Neurodegenerative Disease Specification and Application
9.4.3 Biogen Idec Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 TEVA
9.5.1 TEVA Neurodegenerative Disease Production Sites and Area Served
9.5.2 Neurodegenerative Disease Specification and Application
9.5.3 TEVA Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 UCB
9.6.1 UCB Neurodegenerative Disease Production Sites and Area Served
9.6.2 Neurodegenerative Disease Specification and Application
9.6.3 UCB Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Boehringer Ingelheim
9.7.1 Boehringer Ingelheim Production Sites and Area Served
9.7.2 Neurodegenerative Disease Specification and Application
9.7.3 Boehringer Ingelheim Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Sanofi
9.8.1 Sanofi Neurodegenerative Disease Production Sites and Area Served
9.8.2 Neurodegenerative Disease Specification and Application
9.8.3 Sanofi Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline Neurodegenerative Disease Production Sites and Area Served
9.9.2 Neurodegenerative Disease Specification and Application
9.9.3 GlaxoSmithKline Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served

10 Neurodegenerative Disease Maufacturing Cost Analysis
10.1 Neurodegenerative Disease Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Neurodegenerative Disease
10.4 Neurodegenerative Disease Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Neurodegenerative Disease Distributors List
11.3 Neurodegenerative Disease Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Neurodegenerative Disease Market Forecast
13.1 Global Neurodegenerative Disease Sales, Revenue and Price Forecast
13.1.1 Global Neurodegenerative Disease Sales Growth Forecast (2019-2025)
13.1.2 Global Neurodegenerative Disease Revenue Growth Forecast (2019-2025)
13.1.3 Global Neurodegenerative Disease Price Trend Forecast (2019-2025)
13.2 Global Neurodegenerative Disease Forecast by Region
13.2.1 Global Neurodegenerative Disease Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Neurodegenerative Disease Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Neurodegenerative Disease Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Neurodegenerative Disease Forecast by Type
13.3.1 Global Neurodegenerative Disease Sales Forecast by Type (2019-2025)
13.3.2 Global Neurodegenerative Disease Revenue Forecast by Type (2019-2025)
13.3.3 Global Neurodegenerative Disease Price Forecast by Type (2019-2025)
13.4 Global Neurodegenerative Disease Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Neurodegenerative Disease Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Neurodegenerative Disease Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Neurodegenerative Disease Sales (Feb)
Figure Neurodegenerative Disease Product Picture
Table Global Neurodegenerative Disease Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Neurodegenerative Disease Sales Market Share by Types in 2018
Figure NMDA Product Picture
Figure SSRIs Product Picture
Figure Dopamine Inhibitors Product Picture
Table Global Neurodegenerative Disease Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Neurodegenerative Disease by Application in 2018
Figure Parkinson’s Disease Examples
Figure Huntington Disease Examples
Figure Amyotrophic Lateral Sclerosis Examples
Figure Alzheimer’s Disease Examples
Table Global Market Neurodegenerative Disease Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Neurodegenerative Disease Sales (K Units) Growth Rate (2014-2025)
Figure Global Neurodegenerative Disease Revenue (Million USD) Growth Rate (2014-2025)
Table Global Neurodegenerative Disease Sales (K Units) of Key Companies (2014-2019)
Figure Global Neurodegenerative Disease Sales by Company in 2018
Table Global Neurodegenerative Disease Sales Share by Company (2014-2019)
Figure Global Neurodegenerative Disease Sales Share by Company in 2018
Table Global Neurodegenerative Disease Revenue (Million USD) by Company (2014-2019)
Figure Global Neurodegenerative Disease Revenue (Million USD) by Company in 2018
Table Global Neurodegenerative Disease Revenue Share by Company (2014-2019)
Figure Global Neurodegenerative Disease Revenue Share by Company in 2018
Table Global Neurodegenerative Disease Sales (K Units) Market Share by Region (2014-2019)
Table Global Neurodegenerative Disease Sales Share by Region (2014-2019)
Figure Global Neurodegenerative Disease Sales Share by Region in 2018
Table Global Neurodegenerative Disease Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Neurodegenerative Disease Revenue Share by Region (2014-2019)
Figure Global Neurodegenerative Disease Revenue Market Share by Region In 2018
Table Global Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table Global Neurodegenerative Disease Sales Share by Type (2014-2019)
Figure Global Neurodegenerative Disease Sales Growth Rate by Type in 2018
Table Global Neurodegenerative Disease Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Neurodegenerative Disease Revenue Share by Type (2014-2019)
Figure Global Neurodegenerative Disease Revenue Growth Rate by Type in 2018
Table Global Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Table Global Neurodegenerative Disease Sales Share by Application (2014-2019)
Figure Global Neurodegenerative Disease Sales Market Share by Application in 2018
Figure United States Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure United States Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table United States Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table United States Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure United States Neurodegenerative Disease Sales Market Share by Company in 2018
Table United States Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table United States Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure United States Neurodegenerative Disease Sales Market Share by Type in 2018
Table United States Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table United States Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure United States Neurodegenerative Disease Sales Market Share by Application in 2018
Figure Europe Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table Europe Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table Europe Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure Europe Neurodegenerative Disease Sales Market Share by Company in 2018
Table Europe Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table Europe Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure Europe Neurodegenerative Disease Sales Market Share by Type in 2018
Table Europe Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table Europe Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure Europe Neurodegenerative Disease Sales Market Share by Application in 2018
Figure China Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure China Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table China Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table China Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure China Neurodegenerative Disease Sales Market Share by Company in 2018
Table China Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table China Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure China Neurodegenerative Disease Sales Market Share by Type in 2018
Table China Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table China Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure China Neurodegenerative Disease Sales Market Share by Application in 2018
Figure Japan Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table Japan Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table Japan Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure Japan Neurodegenerative Disease Sales Market Share by Company in 2018
Table Japan Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table Japan Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure Japan Neurodegenerative Disease Sales Market Share by Type in 2018
Table Japan Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table Japan Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure Japan Neurodegenerative Disease Sales Market Share by Application in 2018
Figure Southeast Asia Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table Southeast Asia Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure Southeast Asia Neurodegenerative Disease Sales Market Share by Company in 2018
Table Southeast Asia Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table Southeast Asia Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure Southeast Asia Neurodegenerative Disease Sales Market Share by Type in 2018
Table Southeast Asia Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table Southeast Asia Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure Southeast Asia Neurodegenerative Disease Sales Market Share by Application in 2018
Figure India Neurodegenerative Disease Sales (K Units) and Growth Rate (2014-2019)
Figure India Neurodegenerative Disease Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Neurodegenerative Disease Price (USD/Unit) Trend (2014-2019)
Table India Neurodegenerative Disease Sales (K Units) by Company (2014-2019)
Table India Neurodegenerative Disease Sales Market Share by Company (2014-2019)
Figure India Neurodegenerative Disease Sales Market Share by Company in 2018
Table India Neurodegenerative Disease Sales (K Units) by Type (2014-2019)
Table India Neurodegenerative Disease Sales Market Share by Type (2014-2019)
Figure India Neurodegenerative Disease Sales Market Share by Type in 2018
Table India Neurodegenerative Disease Sales (K Units) by Application (2014-2019)
Table India Neurodegenerative Disease Sales Market Share by Application (2014-2019)
Figure India Neurodegenerative Disease Sales Market Share by Application in 2018
Table Novartis Neurodegenerative Disease Production Sites and Area Served
Table Novartis Neurodegenerative Disease Specification and Application
Table Novartis Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novartis Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Novartis Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Novartis Neurodegenerative Disease Main Business and Markets Served
Table Pfizer Neurodegenerative Disease Production Sites and Area Served
Table Pfizer Neurodegenerative Disease Specification and Application
Table Pfizer Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Pfizer Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Pfizer Neurodegenerative Disease Main Business and Markets Served
Table Merck Serono Neurodegenerative Disease Production Sites and Area Served
Table Merck Serono Neurodegenerative Disease Specification and Application
Table Merck Serono Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck Serono Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Merck Serono Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Merck Serono Neurodegenerative Disease Main Business and Markets Served
Table Biogen Idec Neurodegenerative Disease Production Sites and Area Served
Table Biogen Idec Neurodegenerative Disease Specification and Application
Table Biogen Idec Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Biogen Idec Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Biogen Idec Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Biogen Idec Neurodegenerative Disease Main Business and Markets Served
Table TEVA Neurodegenerative Disease Production Sites and Area Served
Table TEVA Neurodegenerative Disease Specification and Application
Table TEVA Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure TEVA Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure TEVA Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure TEVA Neurodegenerative Disease Main Business and Markets Served
Table UCB Neurodegenerative Disease Production Sites and Area Served
Table UCB Neurodegenerative Disease Specification and Application
Table UCB Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure UCB Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure UCB Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure UCB Neurodegenerative Disease Main Business and Markets Served
Table Boehringer Ingelheim Neurodegenerative Disease Production Sites and Area Served
Table Boehringer Ingelheim Neurodegenerative Disease Specification and Application
Table Boehringer Ingelheim Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Boehringer Ingelheim Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Boehringer Ingelheim Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Boehringer Ingelheim Neurodegenerative Disease Main Business and Markets Served
Table Sanofi Neurodegenerative Disease Production Sites and Area Served
Table Sanofi Neurodegenerative Disease Specification and Application
Table Sanofi Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sanofi Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure Sanofi Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure Sanofi Neurodegenerative Disease Main Business and Markets Served
Table GlaxoSmithKline Neurodegenerative Disease Production Sites and Area Served
Table GlaxoSmithKline Neurodegenerative Disease Specification and Application
Table GlaxoSmithKline Neurodegenerative Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Neurodegenerative Disease Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline Neurodegenerative Disease Revenue Share in International Market (2014-2019)
Figure GlaxoSmithKline Neurodegenerative Disease Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurodegenerative Disease
Figure Manufacturing Process Analysis of Neurodegenerative Disease
Figure Neurodegenerative Disease Industrial Chain Analysis
Table Neurodegenerative Disease Distributors List
Table Neurodegenerative Disease Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Neurodegenerative Disease Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Neurodegenerative Disease Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Neurodegenerative Disease Sales Market Share Forecast by Regions (2019-2025)
Figure Global Neurodegenerative Disease Sales Market Share Forecast by Regions in 2025
Table Global Neurodegenerative Disease Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Neurodegenerative Disease Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Neurodegenerative Disease Revenue Market Share Forecast by Regions in 2025
Figure United States Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Neurodegenerative Disease Revenue and Growth Rate Forecast (2019-2025)
Figure China Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Neurodegenerative Disease Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Neurodegenerative Disease Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Neurodegenerative Disease Sales (K Units) Forecast by Type (2019-2025)
Figure Global Neurodegenerative Disease Sales Market Share Forecast by Type (2019-2025)
Table Global Neurodegenerative Disease Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Neurodegenerative Disease Revenue Market Share Forecast by Type (2019-2025)
Table Global Neurodegenerative Disease Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Neurodegenerative Disease Sales (K Units) Forecast by Application (2019-2025)
Figure Global Neurodegenerative Disease Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources